Carl Zeiss Meditec AGCZMWF 70 Net Margin % is -1.05% as of Dec. 2025. GuruFocus rates CZMWF with a GF Score™ of 70/100 and a GF Value™ of $85.82 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Carl Zeiss Meditec AG ranks better than 60.1% on this metric.
The historical rank and industry rank for Carl Zeiss Meditec AG's Net Margin % or its related term are showing as below:
CZMWF'
s Net Margin % Range Over the Past 10 Years
Min: 5.47 Med: 10.41 Max: 15.45
Current: 5.47
CZMWF's Net Margin % is ranked better than 60.1% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs CZMWF: 5.47
Carl Zeiss Meditec AG (OTCPK:CZMWF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Carl Zeiss Meditec AG Net Margin % Related Terms
Carl Zeiss Meditec AG Net Margin % Historical Data
* Premium members only.
The historical data trend for Carl Zeiss Meditec AG's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carl Zeiss Meditec AG Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Net Margin % distribution charts can be found below:
* The bar in red indicates where Carl Zeiss Meditec AG's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carl Zeiss Meditec AG (CZMWF) has a Net Margin % of -1.05% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Carl Zeiss Meditec AG and its competitors. Over the past decade, Carl Zeiss Meditec AG's Net Margin % has ranged from 5.47 to 15.45. According to the industry distribution chart, Carl Zeiss Meditec AG ranks #326 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 39.9%.
Is Carl Zeiss Meditec AG's Net Margin % too high?
Carl Zeiss Meditec AG's current Net Margin % is -1.05%. Over the past 10 years, this metric has ranged from a low of 5.47 to a high of 15.45. Based on the distribution chart, Carl Zeiss Meditec AG ranks #326 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Carl Zeiss Meditec AG has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Carl Zeiss Meditec AG ranks #326 out of 817 companies for Net Margin %. This puts Carl Zeiss Meditec AG in the upper half of its industry. The industry median Net Margin % is 2.07. Historically, Carl Zeiss Meditec AG's own Net Margin % has ranged from 5.47 to 15.45 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Carl Zeiss Meditec AG and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carl Zeiss Meditec AG's current Net Margin % is -1.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG (CZMWF) is currently considered Significantly Undervalued. The stock's GF Value™ is $85.82, compared to a current price of $31.42 — trading 63.4% below its estimated fair value. The current Net Margin % is -1.05%. Carl Zeiss Meditec AG's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Carl Zeiss Meditec AG (CZMWF), the current Net Margin % is -1.05% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carl Zeiss Meditec AG (CZMWF) Overvalued in 2026?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued.
The current stock price of $31.42 is trading 63.4% below its estimated GF Value™ of $85.82.
GuruFocus considers Carl Zeiss Meditec AG to be Significantly Undervalued.
Key valuation signals for CZMWF:
Net Margin %: -1.05%
GF Value™: $85.82 vs. price of $31.42 (63.4% below fair value)
No single metric tells the full story. See the CZMWF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
70GF Score
Get the complete analysis for CZMWF
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CZMWF has been successfully added to your 
